In 2023, Adam H. Schechter earned $2.40M in total compensation at Labcorp Holdings, including $1.20M salary, $300.00K bonus and $750.00K in stock. Most recently sold 6,189 shares in Nov 2024. Currently holds stock worth $38.73M. Has donated $258.26K in stock to charitable causes. 6+ years at the helm of Labcorp Holdings.
Compensation History
Annual executive compensation data for Adam H. Schechter, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$2.40M
Salary
$1.20M
Bonus
$300.00K
Other
$150.00K
Salary
$1.20MBoard Justification
Labcorp's compensation philosophy is designed to align executive pay with company performance, focusing on long-term value creation and competitive benchmarking against peers.
Bonus
$300.00KBoard Justification
The bonus is based on the company's performance metrics, including revenue growth and operational efficiency, paid out in cash for the fiscal year 2023.
Other Compensation
$150.00KBoard Justification
Other compensation includes retirement contributions, life insurance premiums, and other benefits paid in 2023.
Restricted Stock
Board Justification
5,000 shares of restricted stock units (RSUs) vested in 2023, reflecting the company's stock performance and retention strategy.
Performance Metrics
Performance metrics for 2023 included revenue growth, adjusted earnings per share, and operational efficiency targets.
Adam H. Schechter
CEO of Labcorp Holdings
Sector of Economy
Healthcare
Born
July 30, 2024 - 1 years ago
CEO of Labcorp Holdings for
6 years 1 month (Nov 2019 - Present)
Previous Experience
Unknown
Other Labcorp Holdings CEOs
Holdings
Track Adam H. Schechter's stock holdings and portfolio value over time.
Total Stock Sold
$65.91M
$64.19M
991,981 MRK shares
$1.72M
7,659.132 LH shares
What if they kept their stock?
If Adam H. Schechter didn't sell their stock, today they would have:
Extra MRK991,981 shares worth $98.92M and LH7,659.132 shares worth $1.98M.
This is 53.09% and $34.99M more than what they got when they sold the stock.
Charitable Transactions
710.04 shares
LH
750 shares
MRK
Recent Charitable Transactions
610 shares
LH
Nov 19, 2018
Charity
750 shares
MRK
Dec 15, 2017
Charity
Insider Trading
Adam H. Schechter's recent stock transactions, purchases, and sales filed with the SEC.
$1.51M
LH at $243.47/share
Nov 11, 2024
Sale
42,353 shares
LH
Mar 30, 2023
Received
610 shares
LH
Nov 19, 2018
Charity
$20.51M
MRK at $73.82/share
Nov 1, 2018
Sale
$7.53M
MRK at $70.18/share
Sep 17, 2018
Sale
$8.18M
MRK at $61.00/share
Jun 18, 2018
Sale
$1.87M
MRK at $54.72/share
Feb 27, 2018
Received
$213.81K
LH at $169.29/share
Feb 7, 2018
Sale
$6.26M
MRK at $61.63/share
Jan 16, 2018
Sale
750 shares
MRK
Dec 15, 2017
Charity
Rivals
Compare Adam H. Schechter with competitor CEOs and industry peers.
Brian S. Tyler
CEO of McKesson
2023 Compensation
Stock
$53.90M
Salary
$1.49M
Bonus
$0.00
Other
$864.73K
Total Holdings
$230.10K
August J. Troendle
Founder and CEO of Medpace Holdings, Inc.
2023 Compensation
Stock
$0.00
Salary
$825.00K
Bonus
$814.42K
Other
$17.33K
Total Holdings
$513.58M
James E. Davis
CEO of Quest Diagnostics
2023 Compensation
Stock
$0.00
Salary
$1.18M
Bonus
$1.36M
Other
$346.71K
Total Holdings
$31.88M
Eric M. Green
CEO of West Pharmaceutical Services
2023 Compensation
Stock
$0.00
Salary
$1.14M
Bonus
$1.67M
Other
$92.48K
Total Holdings
$159.06M
Stanley M. Bergman
CEO of Henry Schein
2023 Compensation
Stock
$0.00
Salary
$1.63M
Bonus
$643.65K
Other
$341.74K
Total Holdings
$49.43M